SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-15-001081
Filing Date
2015-02-24
Accepted
2015-02-24 08:31:19
Documents
15
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2223018z10-k.htm 10-K 1481338
2 EX-4.1 a2223018zex-4_1.htm EX-4.1 6381
3 EX-23.1 a2223018zex-23_1.htm EX-23.1 2857
4 EX-31.1 a2223018zex-31_1.htm EX-31.1 8871
5 EX-31.2 a2223018zex-31_2.htm EX-31.2 8878
6 EX-32 a2223018zex-32.htm EX-32 7428
13 G214372.JPG g214372.jpg GRAPHIC 35031
14 G262873KG01I001.GIF g262873kg01i001.gif GRAPHIC 153045
15 G262873KG03I001.GIF g262873kg03i001.gif GRAPHIC 55883
  Complete submission text file 0001047469-15-001081.txt   11834296

Data Files

Seq Description Document Type Size
7 EX-101.INS cldx-20141231.xml EX-101.INS 2128374
8 EX-101.SCH cldx-20141231.xsd EX-101.SCH 59640
9 EX-101.CAL cldx-20141231_cal.xml EX-101.CAL 83769
10 EX-101.LAB cldx-20141231_lab.xml EX-101.LAB 594278
11 EX-101.PRE cldx-20141231_pre.xml EX-101.PRE 392754
12 EX-101.DEF cldx-20141231_def.xml EX-101.DEF 189646
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-15006 | Film No.: 15641884
SIC: 2835 In Vitro & In Vivo Diagnostic Substances